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A genome-wide analysis of putative functional and exonic
variation associated with extremely high intelligence
SL Spain1,8, I Pedroso1,8, N Kadeva1, MB Miller2, WG Iacono2, M McGue2, E Stergiakouli3, GD Smith3, M Putallaz4, D Lubinski5,
EL Meaburn6, R Plomin7 and MA Simpson1
Although individual differences in intelligence (general cognitive ability) are highly heritable, molecular genetic analyses to date
have had limited success in identifying speciﬁc loci responsible for its heritability. This study is the ﬁrst to investigate exome
variation in individuals of extremely high intelligence. Under the quantitative genetic model, sampling from the high extreme of
the distribution should provide increased power to detect associations. We therefore performed a case–control association analysis
with 1409 individuals drawn from the top 0.0003 (IQ 4170) of the population distribution of intelligence and 3253 unselected
population-based controls. Our analysis focused on putative functional exonic variants assayed on the Illumina HumanExome
BeadChip. We did not observe any individual protein-altering variants that are reproducibly associated with extremely high
intelligence and within the entire distribution of intelligence. Moreover, no signiﬁcant associations were found for multiple rare
alleles within individual genes. However, analyses using genome-wide similarity between unrelated individuals (genome-wide
complex trait analysis) indicate that the genotyped functional protein-altering variation yields a heritability estimate of 17.4% (s.e.
1.7%) based on a liability model. In addition, investigation of nominally signiﬁcant associations revealed fewer rare alleles
associated with extremely high intelligence than would be expected under the null hypothesis. This observation is consistent with
the hypothesis that rare functional alleles are more frequently detrimental than beneﬁcial to intelligence.
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INTRODUCTION
General cognitive ability, usually called intelligence, indexes the
covariance among diverse cognitive tests and is one of the best
predictors of important life outcomes such as education,
occupation, and mental and physical health and illness.1–3
Extensive quantitative genetic research consistently indicates that
about half of the total variance of intelligence can be accounted
for by genetic factors.4,5
Unlike psychiatric disorders, intelligence is a normally distrib-
uted quantitative trait with a positive end of high performance as
well as a problematic end of intellectual disability.6 Unlike other
normally distributed behavioural traits, such as personality that
assess average behaviour across situations, intelligence indexes
maximal performance on a battery of tests, analogous to musical
ability and athletic ability.7 These features of intelligence make it
especially well suited phenotypically as a target for positive
genetics—that is, considering the positive end of the normal
distribution of genetic effects rather than focusing on the negative
effects of genetic mutations.8 The investigation of high intelli-
gence could be of particular utility for ﬁnding DNA variants
responsible for the heritability of the entire distribution of
intelligence. The quantitative genetics model proposes that
quantitative traits are inﬂuenced by multiple genes distributed
as a bell-shaped curve, which implies that extremely high
intelligence can be achieved only if an individual has many of
the positive alleles and few of the negative alleles that affect
intelligence. In other words, a large group of individuals of
extremely high intelligence should be enriched for alleles
associated with intelligence and thus yield increased power to
detect associations.9
This quantitative genetics model could be construed to suggest
that the extreme low end of the distribution of intelligence is the
mirror image of the extreme high end. However, it seems likely
that new mutations can more easily disrupt than improve a ﬁnely
tuned performance system, which implies that genetic variation
responsible for the heritability of the entire distribution of
intelligence may be more likely to be found for extremely high
rather than extremely low intelligence. Strong empirical support
for this hypothesis comes from recent studies based on 360 000
sibling pairs and 9000 twin pairs from 3 million 18-year-old males
with cognitive assessments administered as part of conscription
to military service in Sweden. These studies concluded that
extremely high intelligence is as familial and heritable as the rest
of the distribution10 but that extremely low intelligence—severe
intellectual disability—is not familial or heritable.11 The latter
ﬁnding, predicted initially in 1938 by Lionel Penrose,12 suggests
that severe intellectual disability is aetiologically distinct from the
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normal distribution of intelligence, which may explain why DNA
variants recently found to be associated with severe intellectual
disability appear to be rare non-inherited de novo mutations.13–15
Research to date has had limited success in identifying DNA
variants responsible for the heritability of intelligence;16–21 the
‘missing heritability’ problem, is not unique to intelligence—it is
pandemic throughout the life sciences.22 What has been learned
from the whirlwind of genome-wide association (GWA) studies
during the past few years is that the biggest effect sizes for
associations between DNA variants and traits—common disorders
as well as quantitative dimensions—are much smaller than
expected.23 For example, in a GWA meta-analysis of intelligence
for nearly 18 000 children, the largest effect size accounts for
o0.2% of the variance.16 Similar effect sizes were reported in a
recent GWA meta-analysis of intelligence for nearly 54 000
adults.21 If the largest effects are so small, the smallest effects
will be inﬁnitesimal, which means that they will be difﬁcult to
detect in GWA studies and even harder to replicate.24
One strategy for addressing this ‘missing heritability’ problem is
a brute-force approach in which larger samples are amassed in
order to detect associations of smaller effect size using the
common single-nucleotide polymorphisms (SNPs) available on
genome-wide DNA arrays.25 An alternative strategy is to consider
the role of low frequency and rare alleles. The role of rare variants
is well established in monogenic syndromes for which lowered
intelligence is a symptom.26–28 However, it remains unclear to
what extent low frequency and rare alleles contribute to the
genetic architecture of complex traits like intelligence in the
general population, although there have been reports ﬁnding no
association between intelligence and low frequency copy number
variants29–31 and between intelligence and rarer exonic variants;32
one pilot study reported more minor (o1% minor allele
frequency (MAF)) exonic alleles in a higher-IQ group.33
This study capitalises on the increased power of association at
the high extreme of intelligence as a strategy to expedite the
discovery of alleles contributing to variation in intelligence
throughout the distribution. Another novel feature of this study
is its focus on low frequency protein-coding variants in exons
rather than genome-wide common variants. The combination of
these two features is expected to be synergistic because the gain
in power that comes from studying the high extreme is
particularly pronounced for low frequency and rare alleles.9,34
For these reasons, we undertook a threshold-selected case–
control study by obtaining DNA from individuals representing
approximately the top 0.03% of the intelligence distribution and
comparing them with controls drawn from an unselected
population cohort. Within this extreme sampling design, we
investigate the role of common and low frequency protein-coding
variation in intelligence.
MATERIALS AND METHODS
Samples
Data from four samples were used in this study: a sample of high-
intelligence cases, a control sample and two representative samples used
to extend our case–control results to individual differences in the
population. The project received ethical approval from the King’s College
London Research Ethics Committee (reference number PNM/11/12-51) and
from the European Research Council Executive Agency (reference number
Ares(2012)56321).
High-intelligence cases (HiQ). Individuals were recruited from the Duke
University Talent Identiﬁcation Program (TIP), a non-proﬁt organisation
established in 1980 and dedicated to identifying and fostering the
development of academically gifted children35 (see http://www.tip.duke.
edu). Individuals were selected from the United States for participation in
the HiQ study on the basis of performance on the Scholastic Assessment
Test (SAT) or American College Test (ACT) taken at age 12 rather than the
usual age of 18 years. A composite that aggregates verbal and
mathematics SAT and ACT scores correlates 40.80 with intelligence tests
and it is estimated that the TIP program recruits from the top 3% of the
intelligence distribution.36 For this study (HiQ), cases were selected from
the top 1% of these TIP individuals, representing approximately the top
0.03% of the intelligence distribution. Exome array genotyping data were
available for 1759 HiQ individuals who reported their ethnicity as ‘white’.
Following genotyping and quality control (see below), the HiQ sample
included 1409 individuals (818 males).
Unselected controls (MTFS). The Minnesota Twin Family Study (MTFS) is a
population-based study of twins and their parents recruited from
population databases for twins born between 1972 and 1994 in the state
of Minnesota in the United States and tested at ages 11 or 17 (refs 37,38)
(see https://mctfr.psych.umn.edu/). Cognitive ability was measured using a
short form of the Wechsler Adult Intelligence Scale-Revised (WAIS-R) for
participants age 16 or older, or the Wechsler Intelligence Scale for
Children-Revised (WISC-R) for those younger than 16. The short form
consisted of two verbal subtests (information and vocabulary) and two
performance subtests (block design and picture arrangement). An estimate
of full-scale IQ was determined by prorating the scaled scores for these
four subtests; the effective ceiling for the IQ scores was about 150. We
excluded individuals with IQ o70 and those who were not white. We
included 3253 unrelated individuals (1500 males) from MTFS for whom
exome array genotyping and intelligence data were available.
Extension sample 1. The Twins Early Development Study (TEDS) is a
longitudinal UK-based population sample of over 15 000 families with
twins born in England and Wales between 1994, 1995 and 1996 and
identiﬁed from birth records39 (see http://www.teds.ac.uk). Individuals
were tested at 12 years using two verbal and two nonverbal measures. Test
scores were adjusted for age within each testing period, and ﬁrst principal
component scores were derived using principal component analysis
implemented in R. The TEDS sample with genotyping and age 12
intelligence data included 4072 unrelated individuals (1780=males).
Individuals with severe recurrent medical problems or severe perinatal
medical problems were excluded, as were individuals whose ﬁrst language
was not English. Only included individuals who reported their ethnicity as
‘white’ were included.
Extension sample 2. The Avon Longitudinal Study of Parents and Children
(ALSPAC) is a prospective birth cohort, which recruited pregnant women
with expected delivery dates between April 1991 and December 1992 from
Bristol, UK. A total of 14 541 pregnant women were initially enrolled with
14 062 children born. Detailed information on health and development of
children and their parents were collected from regular clinic visits and
completion of questionnaires. A detailed description of the cohort has
been published previously.40,41 The study website contains details of all the
data that is available through a fully searchable data dictionary:
http://www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/. Ethical
approval was obtained from the ALSPAC Law and Ethics Committee and
the local ethics committees. Intelligence in ALSPAC was measured with a
short version of the Wechsler Intelligence Scale for Children (WISC-III) at 8
years of age. Verbal (information, similarities, arithmetic, vocabulary and
comprehension) and performance (picture completion, coding, picture
arrangement, block design and object assembly) subscales were adminis-
tered, each subtest was age scaled according to population norms and a
summary score for total IQ derived. The sample we used included 6461
unrelated individuals (3209 males) who had been tested for intelligence
using a short form of the WISC-III assessment at age 8 years (mean= 8.7
years, s.d. = 0.30) and whose reported ethnicity was ‘white’.
Genotyping and quality control procedures
DNA from cheek swabs was collected by post from 1759 HiQ individuals
and extracted in accordance with standard protocols. DNA was genotyped
using the Illumina HumanExome-12v1-1 array according to the manufac-
turer’s protocols. The control cohort were previously genotyped as part of
the MTFS using the Illumina HumanExome-12v1_A array (San Diego, CA,
USA). We limited our analyses to 242 901 variants present on both versions
of the array.
Provisional genotypes were called using Illumina's GenomeStudio
v2011.1 software. Sample QC was performed on the HiQ and MTFS
cohorts separately using PLINK and R. Samples were removed from
subsequent analyses on the basis of call rate (o0.95), suspected non-
European ancestry, heterozygosity (±4 s.d. from the mean), array signal
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intensity (44 s.d. from the mean) and relatedness (Supplementary
Table 1). SNPs were removed based on the criteria of call rate (o0.99),
deviations from Hardy–Weinberg equilibrium (P o1 × 10− 4) and
GenomeStudio cluster separation score (o0.4). Duplicate assays, tri-allelic
variants and insertion/deletions were also removed from downstream
analysis (Supplementary Table 2). The ZCALL program (see Web resources
section) was used to augment the genotype calling for samples and SNPs
that passed the initial QC. Only samples that achieved a call rate 499%
after ZCALL genotype reﬁnement were included in the analysis.
After a preliminary association analysis, we manually reviewed the
cluster plots for 10 000 variants (ordered by association P-value) using the
EVOKER tool (see Web resources section) and recalled genotypes or
removed SNPs where necessary. During this process, 1083 SNPs were
removed from the analysis owing to poor clustering. A total of 227 858
variants passed QC and were available for analysis (Supplementary Table 2).
The genotype data were converted to VCF format for downstream analysis
using tools within the EPACTS framework (see Web resources section).
Genotyping in the TEDS and ALSPAC extension samples. Genotyping of
rs4713668 was undertaken in the TEDS and ALSPAC samples with a
TaqMan SNP genotyping assay (Applied Biosystems, Life Technologies Ltd,
Paisley, UK).
Statistical analysis
Discovery study
Single-SNP analysis: Analysis was restricted to the 199 039 variants on
the HumanExome array that were successfully genotyped and predicted to
be functional (non-synonymous, stop gain/loss, start gain/loss or splice site
altering) based on annotation performed in EPACTS v3.2.3 using the ‘anno’
option and the default ‘refFlat’ ﬁle (refFlat_hg19.txt.gz) (Supplementary
Table 3). A total of 114 416 variants were polymorphic (minor allele count
40) in the complete data set of HiQ and MTFS individuals, of which 70 112
were polymorphic in each of the HiQ and MTFS data sets. In all, 17 309
variants (MAF 40.01) on the array were assessed for association with a
linear mixed model using the EPACTS v3.2.3 implementation of EMMAX.
Population stratiﬁcation was corrected for using a kinship matrix, which
was created with the ‘make-kin’ function in EPACTS using autosomal SNPs
with a call rate of 40.99 and MAF 40.01 in both HiQ cases and MTFS
controls.
Replication of previously reported cognition-associated variants. Seventeen
cognition-related GWA studies were identiﬁed in the NHGRI GWAS
Catalogue (as of March 2014, Supplementary Table 4), which reported
567 SNPs with P o1× 10− 4. We identiﬁed variants on the exome array
that were either in linkage disequilibrium (LD; r240.6) or within 250 kb of
the previously published variant (Supplementary Table 5). Pairwise LD
relationships were calculated from 1000 genomes (version 3.20101123)
EUR haplotypes using a 500 kb window in the vcftools program (see Web
resources section).
Extension studies. In order to further investigate suggestive hits
(P o5 × 10− 5) to emerge from the main case–control single-SNP analysis,
we performed a quantitative trait analysis using the full distribution of IQ
scores. In the MTFS data set, a kinship matrix was used to correct for
population structure and association was assessed using a linear mixed
model implemented in EMMAX. In the TEDS and ALSPAC data sets, allelic
tests of association were performed using linear regression in PLINK.
Gene-based rare variant analysis. A total of 104 644 rare exonic variants
(MAF o0.01; see Supplementary Table 3) were tested for association in
the discovery case–control sample using a variant-collapsing method
implemented within EPACTS v3.2.3. The analysis was performed using two
different methods, a burden analysis (emmaxCMC) and the optimal
sequence kernel association test (SKAT-O) method (see Web resources
section). Both methods, as implemented in EPACTS, use EMMAX to correct
for population stratiﬁcation. Variants within each gene were assigned to
groups by function to form three different combinations of variants to be
analysed separately: (1) StopGain, Essential Splice Site (ESS) and
NonSynonymous (NS), (2) StopGain, ESS and predicted damaging by
polyphen2 (PP2) and (3) StopGain and ESS.
Estimation of phenotypic variance explained by genotype data. Kinship
matrices were calculated with LDAK software42 using all variants and
estimating weights for all SNPs in a chromosome simultaneously. Principal
components, used as covariates for heritability estimation, were calculated
using the GCTA software43 for variants with MAF 40.05 and polymorphic
in both cases and control data sets. We used GCTA to ﬁt a linear mixed
model to estimate the fraction of phenotypic variance explained by
genotyped variants on the exome array, on both the observed and liability
scale. For individual SNP association, we transformed the case–control
effect size into the corresponding variance explained on a liability scale.44
Increaser/decreaser ratio. The ratio of the number of associated variants
for which the minor allele is at elevated frequency in the high-intelligence
cohort to those in which the minor allele is at elevated frequency in the
control cohort (increaser/decreaser (I/D) ratio) was calculated based on the
method reported recently by Chan et al.45 The beta values for each SNP’s
association were recalculated to reﬂect the effect of the minor allele. The
I/D ratio was calculated for different P-value thresholds (0.01 and 0.001)
and MAF ranges (0.00–0.01, 0.01–0.05, 0.05–0.15, and 0.15–0.50). SNPs
were grouped using the LD-based clumping procedure in PLINKv1.07
(--clump); SNPs that had an r2 40.1 with a SNP with stronger evidence of
association in the locus (deﬁned as a 1 MB window) were removed. In all,
1000 permutations of the single-variant association analysis were
performed to determine the expected distribution under the null
hypothesis and to allow the calculation of P-values for signiﬁcance. The
permuted phenotypes were generated using ‘make-perm-pheno’ function
in PLINK, which preserves the case–control sample number. LD pruning
and the generation of I/D allele counts and ratios were repeated for each
permutation as described above.
I=D ratio ¼ No: associated variants with MA associated with high intelligence
No: associated variants with MA associated with normal intelligence
Z score ¼ observed log2 I=D ratio - μexpected
σexpected
where μ is the mean and σ is the s.d. of the expected log2 I/D ratios.
Squared Z-scores were converted to two-tailed P-values in R using the
chi-squared distribution with 1 degree of freedom.
RESULTS
Study design and statistical power
Following genotyping and quality control, the HiQ sample
included 1409 individuals selectively sampled from the upper tail
of the intelligence distribution and 3253 unselected MTFS
controls. A previous study of intelligence in the TIP cohort derived
a conversion scale relating SAT scores at age 12 years to the
familiar IQ scale (normal distribution with a mean of 100 and s.d.
of 15).36 Using this conversion factor, the successfully genotyped
HiQ cohort has a mean estimated IQ of 176, ranging from 144 to
214 with 93.6 % of the cohort with estimated IQ scores 4170
(Figure 1). This distribution of estimated IQ scores illustrates the
extreme sampling of individuals from the high end of the trait
distribution in comparison with the unselected MTFS controls
(Figure 1). A threshold-selected case–control analysis of this
design provides 80% power to detect associated variants
explaining 40.0015 of the trait variance assuming an additive
model and α= 1× 10− 7.
Single-variant analysis
A case–control association analysis was undertaken with high
quality genotypes at 70 112 common (45%) and low frequency
(1–5%) protein-altering and splice site SNPs from 1409 individuals
from the HiQ cohort and 3253 control subjects. The quantile–
quantile plot indicated adequate control for confounders (λGC =
1.06, Supplementary Figure 1). We explored whether any loci
previously reported to be associated with cognition-related traits
showed evidence of association in our data set. For the 567 SNPs
that had been previously reported, seven were within 250 kb of a
SNP that showed evidence of association (PCC o0.01) with
intelligence in our data set (Supplementary Table 5). One SNP
rs4713668 (P= 4.62 × 10− 4) identiﬁed in our study, was in LD
(r2 = 0.65) with rs3227, which is one of the three variants recently
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reported with genome-wide signiﬁcant evidence of association
with educational attainment.46
Our single-SNP analysis of 70 112 protein-altering and splice site
SNPs that were polymorphic in both the HiQ and MTFS data sets
did not reveal any associations that satisﬁed the genome-wide
signiﬁcant threshold (Supplementary Table 6). However, the most
strongly associated SNP was a missense variant located in PLXNB2
at 22q13 (rs28379706, c.A952G, p.K318E; PCC = 1.31 × 10-5, beta =
− 0.04 ± 0.009, odds ratio = 0.76 (0.69–0.83)), which explains an
estimated 0.16% of the variance (Supplementary Table 7). Given
the unique sampling design used in the HiQ sample, an equivalent
case–control replication cohort is not currently available. However,
the quantitative genetic model suggests that variants associated
with high intelligence will also associate with individual differ-
ences in intelligence throughout the distribution. We therefore
sought to evaluate the role of rs28379706 in the normal
distribution of intelligence in three independent unselected
population cohorts. A nominally signiﬁcant association with
intelligence was observed in the MTFS cohort (PQT = 0.02).
However, we did not observe a signiﬁcant association in either
the TEDS or ALSPAC cohorts (PQT = 0.56 and PQT = 0.94, respec-
tively). The sample sizes of these cohorts, together with the small
effect size of rs28379706 observed in the case–control analysis,
indicates that our power to detect the association is limited in
these cohorts. For this reason, it warrants mention that the allelic
effect was directionally consistent in the discovery case–control
study and all three population cohorts (Supplementary Table 7).
Gene-based rare variant analysis
To address the hypothesis that burden of rare variants (MAF
o0.01) with genes is associated with intelligence, we grouped
variants within each gene by function and applied two gene-
based analyses, CMC and SKAT-O (see Materials and methods
section). A limitation of the CMC method is its reduced power to
detect association when alleles that increase and decrease
intelligence are present in the same gene; SKAT-O models
protective and risk effects. Both tests were performed using a
linear mixed model to control for confounders (quantile–quantile
plots in Supplementary Figure 2). No individual gene reached our
study-wide signiﬁcance threshold using either test (P o3.18 ×
10− 6, based on the analysis of 15 686 genes, Supplementary
Table 8). PLXNB2, which harboured the most strongly associated
common variant, did not demonstrate compelling evidence of
association of rare variation in the gene-based analysis (StopGain_
ESS_NS CMC P= 0.0036; SKAT-O P= 0.0042).
Variance explained by protein-altering variants
To establish the contribution of the genotyped exonic SNPs to the
heritability of intelligence, we used a linear mixed model
implemented in the genome-wide complex trait analysis (GCTA)
framework to estimate the variance explained by the 70 112
functional SNPs used in this analysis. We converted the variance to
a liability scale assuming a population prevalence of 0.0003 based
on the ascertainment criteria for the HiQ sample. The results
suggest that the genotyped protein-altering SNPs (or non-coding
variants that they are tagging) explain 17.4% (1.7% s.e.) of the
variance in intelligence on the liability scale. The observation that
a substantial proportion of the variance of liability to high
intelligence could be explained by these SNPs suggests that these
data could be further explored to gain insight into the genetic
architecture of intelligence.
Ratio of minor allele increaser to decreaser associations
A recent study of the genetic architecture of complex human
diseases and traits elegantly illustrated that an elevated ratio of
the direction of allelic effect (risk to protective in a typical disease
case–control study) of nominally associated rare alleles can be
interpreted as a signature of polygenic inheritance from lower
frequency variants.45 The ratio of associated risk to protective
variants is substantially inﬂuenced by unequal sizes of the case
and control cohorts or uneven population stratiﬁcation. The ratio
must therefore be evaluated in the context of the null distribu-
tion of ratios that is generated through permutation. A risk to
protective ratio for rare alleles that is high in comparison with the
null may be attributed to negative selection keeping detrimental
rare alleles at low frequency. High intelligence may be considered
Figure 1. Extreme sampling of the high cognitive ability cohort. Distribution of general cognitive ability, measured on a standardised IQ scale
(mean 100, s.d. 15), of the high cognitive ability cohort (HiQ, n= 1409, top panel) and the control cohort (MTFS, n= 3253, lower panel). The red
lines illustrate the expected distribution of IQ scores with unbiased sampling.
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as an advantageous rather than detrimental trait. As a result, we
may expect to observe a reduction of the ratio of rare IQ-
increasing alleles to IQ-decreasing alleles (the I/D ratio), indicating
an enrichment of rare intelligence-decreasing alleles or depletion
of rare intelligence-increasing alleles. To test this supposition,
we evaluated this I/D ratio in our data set (see Materials and
methods section, Table 1). We observe a signiﬁcantly lower I/D
ratio for variants within the lowest frequency class (MAF o0.01)
evaluated in comparison with the null. The low ratios are observed
for both 73 variants with a PCCo0.001 (I/Dobs = 8.000, I/Dexp =
32.159, Z-score =− 2.67, PI/D = 0.001) and also 467 variants
with PCC o0.01 (I/Dobs = 3.396, I/Dexp = 6.400, Z-score =− 3.28,
PI/D = 0.008). These results indicate that fewer rare alleles are
associated with high intelligence or more rare alleles are
associated with lower intelligence than would be expected.
DISCUSSION
We have described the results from the ﬁrst investigation of
exome variation in individuals of extremely high intelligence. The
sampling design from the extreme tail of the distribution provides
increased power for the detection of alleles associated with high
intelligence. However, this unique sample also presents challenges
including the absence of a direct replication sample. The strongest
associated single variant identiﬁed in the discovery case–control
analysis is a non-synonymous variant located in the PLXNB2 gene,
whose protein product has been previously implicated in neuronal
migration. Given the unavailability of a direct replication sample,
we sought to evaluate the variant’s association with individual
differences in intelligence across the normal distribution, aware
that power would be limited because the SNP accounted for only
0.16% of variance of a liability model comparing the extremely
high intelligence group and unselected controls. Using this
approach, we were unable to replicate this association observed
in the case–control study, although it is noteworthy that the same
direction of allelic effect was observed in all three extension
cohorts together with the case–control study.
Evaluating the role of all of the genotyped protein-coding
variation on individual differences in intelligence strongly
suggests that such variation does contribute a substantial propor-
tion (about one-ﬁfth) to the variance of the trait. The failure to
detect any single robust association suggests that the contribution
emanates from multiple alleles with effect sizes smaller than this
study’s ability to detect robustly. It is also important to note that
the variance explained by this group of functional SNPs could also
be a consequence of linkage disequilibrium between the coding
variants and non-coding true ‘causal’ SNPs and is therefore an
upper bound of the variance explained by this group of coding
variants. It should also be noted that the heritability of individual
differences in intelligence increases substantially throughout the
lifespan, from about 20% in early childhood, 40% in adolescence
and 60% or higher in adulthood.47 As a result the samples used in
this study were tested in adolescence, our estimates of heritability
may not be as high as they would be in a sample of older adults.
The observed ratio of I/D rare alleles nominally associated with
high intelligence indicates that we observe fewer rare alleles that
are associated with high intelligence or more rare alleles that are
associated with normal intelligence than would be expected.
Although we cannot exclude the possibility that this signal is
driven by asymmetric population stratiﬁcation, this ﬁnding is
consistent with the hypothesis that rare alleles are more
frequently detrimental to intelligence. This hypothesis is important
when considering appropriate study designs for future investiga-
tions. We have demonstrated here the increased power from
extreme sampling as compared with unbiased sampling designs.
For example, a study that maximises power to detect rare alleles
associated with decreased intelligence would ideally seem to use
a low-intelligence sample selected to be as extreme as the high-
intelligence sample in order to ensure balanced sampling.
However, this design may not be advisable because, as noted
earlier, extremely low intelligence is not familial or heritable.11
Instead, a design seems warranted that compares the high-
intelligence group with a group representative of the low end of
the heritable normal distribution of intelligence (that is, between 1
and 2 s.d. below the mean).
As mentioned in the Introduction section, one approach to the
‘missing heritability’ problem is a brute-force approach that moves
toward ever-larger consortia in order to increase power. Although
an intelligence GWA consortium of 54 000 adults was recently
reported, a polygenic score based on this GWA only accounted for
about 1% of the variance of intelligence scores in independent
samples,21 which suggests that very much larger samples will be
needed to narrow the missing heritability gap. This study is novel
in suggesting two alternative strategies to increase power. One
strategy is speciﬁc to intelligence and other normally distributed
traits: selecting individuals extremely high in intelligence. The
other strategy is to move beyond the common SNPs that have
been the focus so far of GWA studies to consider functional exonic
SNPs and rarer SNPs. Although combining these two novel
strategies has suggested that some of the missing heritability
could reside in functional and rarer SNPs, our results indicate that
these strategies are not a panacea to the problem of missing
heritability. Being optimists, we are hopeful that new strategies
will be developed, especially as whole-genome sequencing comes
on line, which will complement the common-SNP, exonic-SNP and
extreme sampling strategies that have been tried so far.
Some remarks about the phenotype under analysis are in order
because they point to a direction for future research as well as a
limitation. Individuals in the profoundly gifted (IQ 4170) group
were identiﬁed by above-level assessment procedures, which
Table 1. Evaluation of the I/D ratio across four MAF ranges (0–0.01, 0.01–0.05, 0.05–0.15 and 0.15–0.50) and two thresholds of nominal signiﬁcance in
the case–control analysis (PCC o0.01 and PCC o0.001)
MAF range Assoc. P No. SNPs Obs. I/D ratio Exp. I/D ratio Observed log2(I/D) Expected log2(I/D) (s.d.) Z-score PI/D
0–0.01 0.01 467 3.396 6.400 1.764 2.652 (0.271) − 3.282 0.001
0–0.01 0.001 73 8.000 32.159 3.000 4.861 (0.697) − 2.668 0.008
0.01–0.05 0.01 62 2.211 1.435 1.144 0.473 (0.369) 1.819 0.069
0.01– 0.05 0.001 6 6.000 2.818 2.585 1.035 (1.222) 1.268 0.205
0.05–0.15 0.01 31 1.000 1.231 0.000 0.209 (0.510) − 0.410 0.682
0.05–0.15 0.001 2 0.500 1.703 − 1.000 0.307 (1.211) − 1.079 0.280
0.15–0.50 0.01 60 0.903 1.098 − 0.147 0.075 (0.416) − 0.533 0.594
0.15–0.50 0.001 6 0.667 1.552 − 0.585 0.103 (1.264) − 0.544 0.586
Abbreviations: I/D, increaser/decreaser; MAF, minor allele frequency; SNP, single-nucleotide polymorphism. The expected I/D ratios were calculated using 1000
permutations of the phenotype to determine the null distribution. The chi-square PI/D values assess the difference between the observed and expected I/D
ratios.
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involved administering standardised college-entrance measures of
quantitative and verbal reasoning to intellectually talented young
adolescents. A composite of quantitative and verbal reasoning
was used to capture general intelligence, which is justiﬁed for
genetic and neurocognitive reasons.6 Such a composite based on
above-level assessment has been shown to capture extremely
high levels of general intellectual functioning with precision, well
beyond 4 s.d. above the population mean.36,48 However,
quantitative reasoning and verbal reasoning predict different
outcomes. For example, 25-year longitudinal studies have
revealed that differences in the quantitative versus verbal prowess
of profoundly gifted youth portend contrasting occupational and
creative accomplishments in scientiﬁc/technical versus humanis-
tic/linguistic endeavours.49,50 For this reason, future research
might proﬁt by considering quantitative and verbal reasoning
separately. In addition, a speciﬁc cognitive ability missing from this
study, spatial ability, should be added to the mix because spatial
ability predicts occupational and creative accomplishments
beyond quantitative and verbal reasoning abilities.51,52
This investigation of protein-altering variation in high intelli-
gence provides clear insight in the role of this class of genetic
variation in the architecture of the trait. A common theme
emerging from genetic studies of intelligence, similar to all
complex traits and common disorders, is its highly polygenic
nature with its heritability explained by many variants of small
effect. Although the unique extreme sampling design used in this
study provides improved power to detect associations in
certain situations it has also provided challenges for direct
replication. Nevertheless, the evidence for the contribution of
protein-altering variants to the heritability of intelligence and the
evidence that rare functional alleles are detrimental to intelligence
provides a framework for deﬁning the role of individual rare
alleles. However, we did not ﬁnd any individual protein-altering
variants that are reproducibly associated with extremely high
intelligence. Thus, despite the power of sampling from the
extreme high end of the distribution of intelligence, we conclude
that these results primarily highlight the complex genetic
architecture of intelligence.
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